Neuroendocrine Tumor (NET) Multidisciplinary Conference

RSS

Add to Calendar Neuroendocrine Tumor (NET) Multidisciplinary Conference 2/3/2023 7:30:00 AM 2/3/2023 8:30:00 AM America/Chicago For More Details: https://mdanderson.cloud-cme.com/course/courseoverview?P=0&EID=24785 Description: This series will provide an opportunity for the highly specialized team to discuss the most challenging cases, including the applicable and evolving literature. Aiming to reach consensus about the optimal individualized approach for each patient discussed, the group will be apprised of the latest advances in the field that directly impact patient care. MD Anderson - Virtual false MM/DD/YYYY


Date & Location
Occurs every 2 weeks on Friday starting on 2/3/2023 at 7:30 AM
Friday, February 3, 2023, 7:30 AM - 8:30 AM, MD Anderson - Virtual, Houston, TX

Target Audience
Specialties - General Surgery
Professions - Nurse - RN, Other, Physician (MD or DO), Physician Assistant, Social Worker, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance (1.00 hours)

Overview
This series will provide an opportunity for the highly specialized team to discuss the most challenging cases, including the applicable and evolving literature. Aiming to reach consensus about the optimal individualized approach for each patient discussed, the group will be apprised of the latest advances in the field that directly impact patient care.


Objectives
At the conclusion of this activity, learners will be able to:

  1. Identify and discuss treatment options for NET patients.
  2. Implement the best treatment plan to provide optimal patient care.

Registration
If you are interested in attending this series, contact Kirby Dooley – Activity Coordinator – at [email protected]

Accreditation
The University of Texas MD Anderson Cancer Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 




Additional Information

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.